Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2
Ret/ptc2 is a constitutively active, oncogenic form of the c-Ret receptor tyrosine kinase. Like the other papillary thyroid carcinoma forms of Ret, Ret/ptc2 is activated through fusion of the Ret tyrosine kinase domain to the dimerization domain of another protein. Investigation of requirements for...
Guardat en:
| Publicat a: | Mol Cell Biol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
1998
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC121481/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9528800/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.18.4.2298 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|